4d Pharma PLC Result of AGM (4105G)
May 26 2017 - 8:59AM
UK Regulatory
TIDMDDDD
RNS Number : 4105G
4d Pharma PLC
26 May 2017
4D pharma plc
(the "Company" or "4D")
Result of AGM
At the annual general meeting of 4D pharma plc (AIM: DDDD), a
pharmaceutical company focusing on the development of live
biotherapeutics, held earlier today, all resolutions put to
shareholders were duly passed.
The full text of each resolution was included in the notice of
the meeting, which was posted to shareholders on 2 May 2017, and is
available on the Company's website www.4dpharmaplc.com.
For further information please contact:
4D + 44 (0)113 895 0130
Duncan Peyton, Chief Executive Officer
Zeus Capital Limited - Nomad and Joint Broker
Dan Bate +44 (0) 161 831 1512
Dominic Wilson +44 (0) 203 829 5000
Investec Bank plc - Joint Broker +44 (0) 207 597 5970
Patrick Robb
Daniel Adams
Carlton Nelson
About 4D
Founded in February 2014, 4D is a world leader in the
development of live biotherapeutics, a novel and emerging class of
drugs, defined by the FDA as biological products that contain a
live organism, such as a bacteria, that is applicable to the
prevention, treatment or cure of a disease. 4D has developed a
proprietary platform, MicroRx, that rationally identifies novel
bacteria that have a precise and evolved therapeutic effect. All of
4D's live biotherapeutic products are orally delivered single
strains of bacteria that are naturally found in the healthy human
gut. 4D currently has a pipeline of 13 preclinical programmes,
covering disease areas such as rheumatoid arthritis, multiple
sclerosis and cancer, and is currently conducting subject trials in
Irritable Bowel Syndrome and Paediatric Crohn's Disease. The
programmes in Paediatric Ulcerative Colitis and Paediatric Crohn's
Disease have both been granted Orphan Drug Status by the FDA.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGBDGDUIUDBGRL
(END) Dow Jones Newswires
May 26, 2017 08:59 ET (12:59 GMT)
4d Pharma (LSE:DDDD)
Historical Stock Chart
From Apr 2024 to May 2024
4d Pharma (LSE:DDDD)
Historical Stock Chart
From May 2023 to May 2024